Appendix A
Agenda
FORUM ON EMERGING INFECTIONS
Board on Global Health
Institute of Medicine
The National Academies
THE IMPACT OF GLOBALIZATION ON INFECTIOUS DISEASE EMERGENCE AND CONTROL: EXPLORING THE CONSEQUENCES AND OPPORTUNITIES
April 16–17, 2002
AGENDA
Tuesday, April 16, 2002
8:30 |
Continental Breakfast |
9:00 |
Welcome and Opening Remarks Adel Mahmoud, President, Merck Vaccines Chair Forum on Emerging Infections |
Session I: The Global Movement of Populations, Products, and Pathogens
Moderator: James Hughes, Assistant Surgeon General and Director, National Center for Infectious Diseases, CDC |
|
9:15 |
The World and Its Moving Parts Martin Cetron, Deputy Director, Division of Quarantine, National Center for Infectious Diseases, CDC |
9:35 |
Global Migration and Infectious Diseases Danielle Grondin, Director, Migration Health Services, International Organization of Migration |
9:55 |
Globalization of the Food Supply David Acheson, Chief Medical Officer, Food Safety and Inspection Service, USDA |
10:15 |
Changing Vector Ecologies: Political Geographic Perspectives Jonathan Mayer, Professor, Geography, College of Arts and Sciences, University of Washington, Seattle |
10:35 |
BREAK |
10:50 |
Invited Discussion: A Response to the Shifting Trends |
|
Moderator: Margaret Hamburg, Vice-President, Biologicals Program, Nuclear Threat Initiative Stephen Corber, Director, Division of Disease Prevention and Control, Pan American Health Organization Mary Wilson, Professor of Medicine, Harvard Medical School, Population and International Health Judith Miller, Journalist, the New York Times David Heyman, Senior Fellow, Center for Strategic and International Studies |
12:30 |
Lunch |
Session II: Addressing the Health Challenges from Globalization
Moderator: Patrick Kelley, Director, DoD Global Emerging Infections Surveillance and Response Systems, Walter Reed Army Institute of Research |
|
1:30 |
The Global Infectious Disease Threat David Gordon, Intelligence Officer, Economics and Global Health Issues, National Intelligence Council |
1:50 |
Health, Human Rights, and Humanitarian Assistance: The Medical and Public Health Response to Crises and Disasters Jennifer Leaning, Professor, Population and International Health, Harvard University |
2:10 |
Social Aspects of Public Health Challenges in a Period of Globalization: The Case of Russia Andrey Demin, President, Russian Public Health Association and Professor, I.M. Sechenov Medical Academy, Moscow |
2:30 |
Considerations for Drug Access and Delivery in the Developing World Robert Redfield, Professor and Associate Director, Institute of Human Virology, University of Maryland, Baltimore |
2:50 |
Impediments to Global Surveillance and Open Reporting of Infectious Diseases Richard Cash, Lecturer on International Health, Harvard School of Public Health |
3:10 |
International Law, Infectious Disease, and Globalization David Fidler, Professor of Law and Ira C. Batman Faculty Fellow, School of Law, Indiana University |
3:30 |
BREAK |
3:45 |
Invited Discussion: Considering the Resources and Capacity for the Response |
|
Moderator: Stanley Lemon, Dean of Medicine, University of Texas, Medical Branch, Galveston Farley Cleghorn, Senior Scientist, Institute of Human Virology, University of Maryland, Baltimore Ann Marie Kimball, Professor, Epidemiology and Health Services, University of Washington, Seattle Michele Barry, President, American Society of Tropical Medicine and Hygiene, Professor, Yale University, School of Medicine Jonathan Patz, Associate Professor, Bloomberg School of Public Health, Johns Hopkins University |
5:30 |
Adjournment of the first day |
5:45 |
Reception, Members Room of the NAS |
6:15 |
Dinner Meeting for Forum Members |
Wednesday, April 17, 2002
8:30 |
Continental Breakfast |
9:00 |
Opening Remarks/Day One Summary Stanley Lemon Vice-Chair, Forum on Emerging Infections |
Session III: Creating Opportunities from Globalization: A Framework for Progress
Moderator: Michael Zeilinger, Public Health Advisor, Team Leader, Infectious Diseases, USAID |
|
9:15 |
Globalization and Health: A Framework for Analysis and Action Douglas Klaucke, Communicable Disease Surveillance and Response, World Health Organization |
9:35 |
New Directions in Capacity Building Pierce Gardner, Senior Advisor for Clinical Research and Training, Fogarty International Center, NIH |
9:55 |
Partnering for Success: The Role of Private-Public Sector Collaboration Roy Widdus, Project Manager, Initiative for Public-Private Partnerships for Health, Geneva |
10:15 |
The Current Situation and Perspectives of International Collaboration in the Field of Biomedical Sciences: The Example of the State Research Center of Virology and Biotechnology (VECTOR) Sergei Netesov, Deputy Director, VECTOR Laboratories, Koltsovo, Russia |
10:35 |
Protecting the Nation’s Health in an Era of Globalization, CDC’s Global Infectious Disease Strategy Eric Mintz, Acting Associate Director for Global Health, CDC |
10:55 |
The Global Fund: A Brave New World William Steiger, Special Assistant to the Secretary, International Affairs, Department of Health and Human Services |
11:15 |
BREAK |
11:30 |
Invited Discussion: Considerations for Shaping the Agenda |
Moderator: Carlos Lopez, Research Fellow, Eli Lilly and Company |
|
|
Olusoj Adeyi, Senior Health Specialist, World Bank William Makgoba, President, Medical Research Council of South Africa (by teleconference) Mark Miller, Associate Director for Research and Director, Division of International Epidemiology and Population Studies, Fogarty International Center, NIH Ralph Timperi, Chair, APHL Global Health Committee and Assistant Commissioner/Director, State Laboratory Institute Massachusetts Department of Public Health |
1:00 |
Lunch |
Session IV: The Global Application of Tools, Technology, and Knowledge to Counter the Consequences of Infectious Diseases: A Discussion of Priorities and Options
2:00 |
With the backdrop of the two days’ presentations and discussion, Forum members, panel discussants, and the audience will comment on the issues and next steps that they would identify as priority areas for consideration within industry, academia, government agencies, public health organizations, and other nongovernmental organizations. The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the options and considerations for research, development, and capacity building. The complexities of interactionamong private industry, research and public health agencies, regulatory agencies, policymakers, academic researchers, and the public will be explored with an eye toward innovative responses to the challenges and opportunities presented by an increasingly “globalized” world. |
Moderator: Adel Mahmoud, President, Merck Vaccines |
|
Invited Panel Discussants: Eduardo Gotuzzo, President, Latin American Society of Tropical Medicine and Principal Professor, University Perudad Cayetano Heredia, Peru Reinhard Kurth, President, the Robert Koch Institute, Berlin Jim LeDuc, Acting Director, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention |
3:30 |
Roundtable Discussion |
4:30 |
Closing Remarks / Adjournment Adel Mahmoud, President, Merck Vaccines Chair, Forum on Emerging Infections |